No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleonly males |
244368 |
2. Check conditionsNone |
244368 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
694 |
4. Check minimum number of eventsNone |
694 |
5. Include endpoints |
831 |
6. Filter based on genotype QC (FinnGen only) |
760 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF3
- Parent code in ICD-10
- D10-D36
- Name in latin
- Neoplasmata benigna organorum genitalium masculinorum
Benign neoplasm of male genital organs
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5564 | - | 5564 |
| Only index persons | 4801 | - | 4801 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.16 | - | 0.16 |
| Only index persons | 0.18 | - | 0.18 |
| Median age at first event (years) | |||
| Whole population | - | - | 52.91 |
| Only index persons | - | - | 50.02 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 760 | - | 760 |
| Unadjusted period prevalence (%) | 0.35 | - | 0.35 |
| Median age at first event (years) | 59.09 | - | 59.09 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 786
- Matched controls
- 7860
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D29.1
ICD-10 Finland
Benign neoplasm: Prostate
446.5
259.0
246
8
D29.2
ICD-10 Finland
Benign neoplasm: Testis
1468.3
131.1
124
*
D29.4
ICD-10 Finland
Benign neoplasm: Scrotum
268.9
115.1
115
5
D29.3
ICD-10 Finland
Benign neoplasm: Epididymis
615.1
110.7
107
*
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
33.7
105.2
68
22
KFC00
NOMESCO Finland
Unilateral orchiectomy
17.2
73.4
62
39
D29.0
ICD-10 Finland
Benign neoplasm: Penis
+∞
55.9
53
*
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
6.0
47.8
91
169
22200
ICD-8 Finland
Benign neoplasm of male genital organs, Testis
+∞
27.2
26
*
22288
ICD-8 Finland
Benign neoplasm of male genital organs, Loco alio definito
+∞
26.2
25
*
KFD16
NOMESCO Finland
Partial excision of epididymis
31.2
25.2
33
11
2223A
ICD-9 Finland
Benign neoplasm of male genital organs, Epididymis
+∞
18.8
18
*
KFA00
NOMESCO Finland
Exploration of testis
22.4
18.3
26
12
D29.9
ICD-10 Finland
Benign neoplasm: Male genital organ, unspecified
+∞
17.8
17
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.8
17.2
53
145
2220A
ICD-9 Finland
Benign neoplasm of male genital organs, Testis
+∞
16.7
16
*
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
2.1
14.6
156
818
22210
ICD-8 Finland
Benign neoplasm of male genital organs, Penis
+∞
14.6
14
*
Y05
ICPC
Scrotum/testis sympt/compl other
4.7
14.3
33
72
C61
ICD-10 Finland
Malignant neoplasm of prostate
2.0
14.3
176
974
ZXC96
NOMESCO Finland
Robot assisted procedure
3.6
13.7
45
129
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
76.5
13.6
15
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.9
13.0
208
1253
KGB00
NOMESCO Finland
Biopsy of penis
23.0
12.9
18
8
N43.4
ICD-10 Finland
Spermatocele
3.7
12.7
41
116
XKD00
NOMESCO Finland
Uroflowmetry
1.8
12.6
239
1518
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
2.0
12.6
165
929
22280
ICD-8 Finland
Benign neoplasm of male genital organs, Scroti
+∞
12.5
12
*
D29.7
ICD-10 Finland
Benign neoplasm: Other male genital organs
+∞
12.5
12
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
3.2
12.4
49
158
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
3.4
12.4
44
133
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
47.4
11.9
14
*
UKC02
NOMESCO Finland
Cystoscopy
1.8
11.3
197
1213
N40
ICD-10 Finland
Hyperplasia of prostate
1.7
11.3
357
2600
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
11.0
149
845
J01DB01
ATC
cefalexin; oral
1.8
10.9
619
5256
XJH00
NOMESCO Finland
Transanal ultrasonography
2.2
10.2
97
483
NK6AN
NOMESCO Finland
Total body bone isotope imaging
3.1
9.0
37
123
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
12.9
8.4
14
11
7501
FHL
Testicular exploration (includes removal of biopsy, detorsion or appendix test)
12.9
8.4
14
11
22299
ICD-8 Finland
Benign neoplasm of male genital organs, Unspecified site
+∞
8.3
8
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.1
8.3
83
422
G04CA02
ATC
tamsulosin; oral
1.5
8.0
355
2735
D40.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other male genital organs
22.3
8.0
11
5
J01MA02
ATC
ciprofloxacin; systemic
1.6
8.0
324
2447
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
7.6
200
1363
KFD96
NOMESCO Finland
Other excision or ligature of scrotal organs
80.8
7.4
8
*
C05AA08
ATC
fluocortolone; rectal, topical
1.9
7.4
101
573
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
7.3
218
1531
KFW96
NOMESCO Finland
Other operation on scrotum or scrotal organs
20.2
7.1
10
5
N50.8
ICD-10 Finland
Other specified disorders of male genital organs
4.3
7.0
18
43
S18
ICPC
Laceration/cut
1.5
6.9
361
2855
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
40.4
6.8
8
*
M02AA10
ATC
ketoprofen; topical
1.8
6.7
107
637
KFD70
NOMESCO Finland
Excision of lesion of skin of scrotum
26.9
6.2
8
*
KFD30
NOMESCO Finland
Operation for spermatocele
4.0
6.2
17
43
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
46
28
17.39
55.14
3.8
2.3
27.34
63.84
u/l
—
7
5
579
4852
1.73
10.27
7.0
5.7
2.64
2.88
ug/l
0.20
513
4375
139
799
1.90
9.82
5.9
5.1
30.78
30.84
%
0.02
88
530
488
4058
1.53
7.57
5.6
4.5
129.10
283.21
e6/l
—
10
72
173
1166
1.62
6.82
2.8
2.4
13.19
13.76
nmol/l
0.40
151
1047
430
3572
1.45
6.08
17.8
19.2
1.33
1.35
inr
0.30
364
3023
430
3580
1.44
5.96
7.2
7.7
11.91
13.25
umol/l
2.44
417
3440
408
3390
1.42
5.56
2.5
2.6
—
—
—
0
0
149
1021
1.57
5.39
4.7
4.3
228.48
246.22
u/l
1.55
141
968
366
3000
1.41
5.30
2.2
2.3
94.40
92.67
pmol/l
0.27
207
1760
12
18
6.75
5.27
1.8
4.3
3.08
5.66
ug/l
1.08
12
18
373
3082
1.40
5.09
7.7
8.2
1.20
1.20
mmol/l
0.99
338
2862
407
3419
1.39
5.01
8.4
9.0
1.20
1.20
mmol/l
0.22
341
2955
559
4963
1.44
4.97
9.6
9.3
78.47
81.78
u/l
0.93
531
4734
43
208
2.13
4.94
1.7
1.4
7.95
5.85
u/l
0.51
30
166
477
4135
1.39
4.75
5.5
6.2
6.69
6.94
mmol/l
2.20
458
3990
364
3050
1.36
4.32
2.8
3.1
—
—
estimate
—
0
0
679
6318
1.55
4.27
25.2
24.1
4.01
4.04
mmol/l
1.68
666
6202
310
2539
1.36
4.23
2.4
2.3
75.79
74.66
nmol/l
0.31
267
2264
591
5361
1.41
4.18
4.4
4.2
1.91
2.03
mu/l
1.30
528
4876
677
6303
1.53
4.16
25.1
23.9
139.66
139.64
mmol/l
0.08
664
6192
49
273
1.85
3.84
1.8
1.8
—
—
—
0
0
659
6130
1.46
3.78
20.8
19.5
29.97
29.96
mg/l
0.00
568
5204
52
299
1.79
3.69
2.1
2.0
—
—
—
0
0
266
2166
1.34
3.66
3.3
3.0
66.51
96.72
u/l
0.38
251
2041
692
6534
1.49
3.32
27.6
25.4
91.54
91.14
umol/l
0.11
680
6466
67
430
1.61
3.21
2.3
1.8
—
—
—
0
0
10
24
4.21
3.20
2.6
3.9
4.99
5.00
kpa
—
10
24
10
24
4.21
3.20
2.6
3.9
9.04
10.12
kpa
—
10
24
318
2698
1.30
3.17
3.1
3.1
180.67
195.78
ug/l
0.46
290
2495
62
393
1.63
3.13
2.2
1.8
—
—
—
0
0
105
757
1.45
2.96
8.1
8.5
—
—
—
0
0
629
5872
1.36
2.93
20.7
18.8
76.82
78.22
ml/min/173m2
0.86
585
5506
266
2226
1.29
2.89
3.2
3.8
33.09
38.37
u/l
1.29
247
2107
506
4593
1.29
2.85
4.7
4.2
11.96
12.82
mm/h
0.57
469
4280
17
71
2.43
2.81
2.3
1.3
9.55
11.20
iu/l
0.24
11
55
173
1372
1.33
2.76
1.9
2.0
—
—
—
0
0
643
6039
1.36
2.76
5.4
5.4
4.25
4.31
mmol/l
0.77
585
5623
336
2912
1.27
2.72
3.9
3.3
0.69
0.78
ug/l
1.59
231
1926
697
6637
1.44
2.72
31.4
28.7
229.64
230.32
e9/l
0.10
684
6496
697
6639
1.44
2.69
31.3
28.6
91.21
91.56
fl
1.24
689
6557
697
6641
1.44
2.67
31.4
28.6
4.56
4.56
e12/l
0.06
679
6483
697
6641
1.44
2.67
31.9
29.5
41.08
41.73
%
0.44
689
6551
697
6642
1.44
2.66
31.6
28.9
137.85
138.49
g/l
0.44
690
6560
473
4279
1.26
2.63
3.8
3.7
52.77
60.68
u/l
1.31
439
4029
52
333
1.60
2.56
5.0
4.3
24.00
24.92
mmol/l
1.76
45
309
281
2408
1.26
2.45
4.2
3.7
40.87
131.96
e6/l
1.85
225
1902
627
5898
1.31
2.42
5.8
5.4
6.03
6.15
mmol/l
1.81
559
5376
258
2192
1.26
2.41
2.5
2.3
337.54
279.85
u/l
0.24
246
2078
636
6000
1.31
2.36
5.5
5.3
1.31
1.29
mmol/l
0.64
579
5538
367
3255
1.24
2.32
4.2
3.7
0.00
0.00
estimate
-0.00
79
714
371
3296
1.24
2.31
4.3
3.7
0.00
2.44
estimate
0.50
78
718
371
3301
1.23
2.26
4.3
3.7
0.00
0.46
estimate
0.51
72
657
459
4187
1.23
2.17
3.3
3.3
14.98
14.95
pmol/l
0.07
413
3780
45
292
1.57
2.13
2.1
2.9
1.03
1.60
g/l
0.50
36
260
675
6448
1.33
2.09
14.0
13.0
28.04
29.30
u/l
0.82
648
6276
58
404
1.47
2.00
2.0
2.0
37.15
39.26
nmol/l
0.30
58
388
431
3928
1.22
1.98
5.1
4.7
20.12
21.43
%
1.15
227
1960
17
84
2.05
1.97
1.5
2.9
27.00
21.41
mg/l
—
5
32
16
78
2.07
1.92
1.7
1.4
113.16
166.56
pmol/l
1.41
16
78
238
2051
1.23
1.90
1.7
1.8
18.45
18.92
nmol/l
0.20
192
1744
406
3690
1.21
1.88
9.9
10.3
4.46
4.39
e9/l
0.21
361
3202
644
6139
1.27
1.84
6.1
6.0
2.48
2.54
mmol/l
0.91
588
5680
238
2061
1.22
1.80
4.0
3.6
0.91
0.47
e6/l
0.58
178
1572
317
2825
1.20
1.79
4.6
4.3
37.07
79.02
ng/l
1.11
252
2216
138
1128
1.27
1.75
2.8
3.0
22.29
23.65
%
0.58
127
1058
0
46
0.00
1.71
0.0
1.2
—
21.22
—
0
40
609
5784
1.23
1.70
4.6
4.5
1.30
1.34
mmol/l
0.63
543
5309
0
48
0.00
1.70
0.0
1.2
—
79.29
—
0
42
153
1275
1.25
1.65
1.8
1.8
1133.59
1157.67
nmol/l
0.09
107
986
36
238
1.54
1.63
1.3
1.4
—
—
—
0
0
29
182
1.62
1.62
1.6
1.5
—
—
—
0
0
283
2517
1.19
1.59
1.9
2.0
1.38
1.39
mmol/l
0.08
244
2078
199
1714
1.22
1.57
3.4
2.8
2.36
2.96
e6/l
1.07
184
1553
146
1218
1.24
1.56
2.7
3.0
2.16
2.20
g/l
0.34
132
1137
47
332
1.44
1.56
2.6
2.7
4.03
4.12
g/l
0.31
40
306
47
332
1.44
1.56
2.6
2.7
6.98
7.17
g/l
0.33
40
305
47
332
1.44
1.56
2.6
2.7
3.80
3.58
g/l
0.30
40
305
83
645
1.32
1.55
3.0
2.7
37.03
41.02
u/l
0.22
74
554
41
282
1.48
1.55
2.4
2.9
9.40
11.24
g/l
1.74
33
255
155
1303
1.24
1.55
3.6
3.3
1.01
0.88
e6/l
0.20
88
760
268
2378
1.19
1.54
3.6
3.5
1976.22
1898.50
ng/l
0.08
227
2094
55
404
1.39
1.48
2.0
2.0
1.47
1.48
ug/l
0.01
44
361
9
37
2.45
1.48
2.4
2.1
—
—
—
0
0
9
37
2.45
1.48
2.4
2.1
—
—
—
0
0
9
37
2.45
1.48
2.4
2.1
—
—
—
0
0
9
37
2.45
1.48
2.4
2.1
—
—
—
0
0
107
1307
0.79
1.48
3.9
3.4
2.46
2.45
mmol/l
0.41
98
1178
341
3099
1.18
1.47
5.5
6.2
34.92
34.87
g/l
0.05
312
2911
16
87
1.86
1.46
2.9
3.3
—
—
—
0
0
79
616
1.31
1.46
4.9
4.0
4.96
5.13
kpa
1.19
74
593
44
312
1.43
1.44
1.7
2.7
2.67
2.92
g/l
1.35
37
286
6
22
2.74
1.43
7.0
7.2
10.50
7.45
%
—
6
22
213
1864
1.20
1.42
2.4
2.3
3.01
2.87
mg/l
0.35
181
1612
215
1884
1.19
1.41
4.3
3.8
0.00
0.01
estimate
0.96
74
627
39
272
1.46
1.40
2.8
3.4
1.48
2.41
ratio
1.32
27
157
23
142
1.64
1.39
1.1
1.3
—
—
—
0
0
15
82
1.85
1.36
1.9
1.6
—
—
—
0
0
194
1693
1.19
1.33
2.7
2.8
—
—
—
0
0
152
1297
1.21
1.32
2.7
3.0
12.29
13.00
umol/l
0.57
140
1217
15
83
1.82
1.32
1.9
1.6
—
—
—
0
0
15
83
1.82
1.32
1.9
1.6
—
—
—
0
0
15
83
1.82
1.32
1.9
1.6
—
—
—
0
0
15
83
1.82
1.32
1.9
1.6
—
—
—
0
0
85
681
1.28
1.30
3.4
3.0
66.11
66.14
g/l
0.01
73
634
54
406
1.35
1.29
1.6
1.5
—
—
—
0
0
8
36
2.23
1.24
2.3
1.3
0.14
0.16
nmol/l
—
8
22
166
1444
1.19
1.18
4.0
4.1
188.59
451.58
ng/l
1.55
144
1235
144
1239
1.20
1.16
3.8
3.4
1.19
0.58
e6/l
0.70
80
694
22
142
1.57
1.15
1.4
1.3
—
36.00
—
0
5
11
58
1.91
1.12
1.5
1.5
—
—
—
0
0
14
81
1.74
1.09
1.9
1.6
—
—
—
0
0
8
41
1.96
1.09
1.4
1.5
—
—
—
0
0
8
41
1.96
1.09
1.4
1.5
—
—
—
0
0
7
32
2.20
1.08
2.9
2.1
—
—
—
0
0
7
32
2.20
1.08
2.9
2.1
—
—
—
0
0
11
59
1.88
1.07
3.4
2.8
7.73
8.39
mmol/l
0.38
11
59
123
1052
1.20
1.06
1.7
1.9
—
—
—
0
0
7
33
2.13
1.05
2.9
2.1
—
—
—
0
0
608
5859
1.17
1.04
7.6
7.0
39.91
40.27
mmol/mol
0.44
544
5469
10
53
1.90
1.01
1.3
1.5
—
—
—
0
0
44
335
1.33
1.01
2.8
2.4
1141.13
572.16
ug/l
0.28
39
327
219
1978
1.15
0.97
3.3
3.2
371.07
378.00
umol/l
0.55
195
1739
7
36
1.95
0.97
1.9
1.9
82.43
127.95
ng/l
—
7
36
17
108
1.59
0.97
3.6
2.4
—
—
—
0
0
32
234
1.38
0.95
1.4
2.9
0.00
0.00
g/l
-0.00
27
205
23
158
1.47
0.94
1.2
1.5
—
—
—
0
0
67
546
1.25
0.93
4.1
3.1
60.39
62.65
ml/min/173m2
0.24
36
239
6
27
2.23
0.93
1.0
1.1
—
—
—
0
0
96
813
1.21
0.93
2.8
3.3
9.69
10.36
umol/l
0.09
83
742
30
219
1.38
0.90
1.7
1.7
—
—
—
0
0
8
43
1.87
0.87
1.4
1.1
83.63
101.49
pmol/l
—
8
43
94
801
1.20
0.87
3.3
4.3
1.83
1.74
mmol/l
0.09
80
675
33
247
1.35
0.86
1.5
2.9
0.03
0.01
g/l
0.28
28
222
271
2501
1.13
0.86
4.3
3.7
0.00
0.02
estimate
1.32
68
608
26
187
1.40
0.86
1.2
1.5
—
—
—
0
0
8
45
1.79
0.84
2.7
2.9
—
—
—
0
0
21
146
1.45
0.83
3.5
2.0
1.00
0.89
nmol/l
0.38
16
129
59
482
1.24
0.82
4.8
5.2
103.37
116.11
ng/l
0.34
52
426
15
97
1.56
0.81
3.8
2.4
—
—
—
0
0
13
81
1.62
0.81
1.1
1.4
8.57
6.78
u/ml
—
7
45
64
529
1.23
0.81
4.9
3.9
0.70
1.85
mmol/l
1.61
47
388
67
558
1.22
0.79
1.8
1.8
—
—
—
0
0
0
24
0.00
0.79
0.0
1.4
—
—
—
0
0
6
34
1.77
0.76
1.0
4.0
—
49616.00
—
0
9
10
59
1.70
0.76
1.0
1.1
—
—
—
0
0
9
53
1.71
0.75
1.3
1.5
—
—
—
0
0
6
110
0.54
0.72
1.3
1.4
—
—
—
0
0
21
151
1.40
0.72
1.9
1.9
—
—
—
0
0
14
205
0.68
0.70
1.1
1.6
—
—
—
0
0
17
118
1.45
0.69
1.6
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
40
322
1.26
0.66
2.0
2.6
0.33
0.33
iu/ml
0.01
20
165
5
28
1.79
0.66
1.8
1.3
12.60
9.43
mm/h
—
5
28
191
1767
1.11
0.58
4.0
3.3
0.02
0.07
estimate
0.54
63
547
11
73
1.51
0.56
1.1
1.1
—
—
—
0
0
61
524
1.18
0.56
1.5
1.5
—
—
—
0
0
28
222
1.27
0.54
1.8
1.8
—
—
—
0
0
46
543
0.84
0.53
2.0
2.1
3.47
3.79
ratio
1.05
38
440
162
1495
1.11
0.52
5.1
3.9
1.02
1.02
kg/l
0.89
131
1018
45
379
1.20
0.52
2.6
2.5
9.26
18.60
au/ml
—
5
37
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
40
1.50
0.51
1.0
1.2
—
—
—
0
0
140
1285
1.11
0.50
4.0
3.7
0.80
0.82
mmol/l
1.44
130
1225
25
312
0.79
0.49
4.2
4.0
346.90
4326.52
u/ml
0.66
20
265
92
825
1.13
0.49
3.4
4.3
5.81
5.84
kpa
0.11
92
800
159
1471
1.10
0.49
1.8
1.8
101538889.62
17441331.46
pmol/l
0.60
130
1227
50
429
1.18
0.48
1.3
1.9
1.75
1.52
g/l
0.86
40
383
14
188
0.74
0.47
2.1
2.6
124.38
130.07
g/l
—
8
149
12
85
1.42
0.47
2.2
2.1
—
—
—
0
0
97
877
1.12
0.46
1.3
1.3
65.58
34.60
iu/ml
0.47
25
244
18
138
1.31
0.45
1.3
1.5
—
—
—
0
0
20
156
1.29
0.45
3.3
3.8
35.07
32.41
mg/l
0.06
12
116
5
31
1.62
0.43
1.2
1.1
—
—
—
0
0
25
203
1.24
0.42
1.0
1.0
—
—
—
0
0
5
32
1.57
0.42
1.8
2.0
435.60
1621.72
u/ml
—
5
32
123
1137
1.10
0.40
1.3
1.2
1.02
1.21
u/ml
0.29
29
316
5
35
1.43
0.39
1.2
1.2
—
—
—
0
0
10
71
1.41
0.39
2.3
1.8
—
—
—
0
0
10
71
1.41
0.39
2.3
1.8
—
—
—
0
0
10
71
1.41
0.39
2.3
1.8
—
—
—
0
0
20
160
1.26
0.39
1.3
1.5
—
—
—
0
0
38
326
1.17
0.39
3.8
3.1
24.83
24.64
mmol/l
0.12
38
321
17
214
0.79
0.38
3.1
2.4
101.22
117.36
ug/min
—
9
126
5
36
1.39
0.38
4.2
1.3
40.48
39.21
g/l
—
5
36
82
745
1.11
0.38
3.1
2.6
0.21
0.20
g/l
0.18
76
682
11
81
1.36
0.36
2.3
2.1
—
—
—
0
0
27
226
1.20
0.36
1.4
1.4
—
—
—
0
0
6
45
1.34
0.34
2.2
2.3
24.67
16.18
%
—
6
45
23
191
1.21
0.33
1.2
1.4
1.15
1.16
g/l
0.09
23
184
83
904
0.91
0.33
2.1
2.0
1.57
1.62
%
0.22
70
773
15
119
1.27
0.32
3.2
4.1
6.00
12.19
pmol/l
4.08
15
119
7
98
0.71
0.31
1.0
1.0
—
—
—
0
0
76
698
1.10
0.30
1.6
1.3
—
—
—
0
0
18
148
1.22
0.29
1.2
1.6
—
—
—
0
0
23
195
1.18
0.28
1.0
1.1
1.45
1.43
g/l
0.17
23
195
42
375
1.13
0.28
2.7
3.8
25.00
25.05
mmol/l
0.03
42
358
16
193
0.83
0.27
1.2
1.6
—
—
—
0
0
8
67
1.20
0.26
1.3
1.1
—
—
—
0
0
17
141
1.21
0.26
1.2
1.1
—
—
—
0
0
17
141
1.21
0.26
1.2
1.1
—
—
—
0
0
5
71
0.70
0.26
1.0
1.2
—
—
—
0
0
10
77
1.30
0.26
1.9
1.9
—
—
—
0
0
22
188
1.18
0.25
1.2
1.3
0.22
0.24
g/l
0.64
22
180
24
207
1.16
0.25
1.1
1.2
0.95
0.94
g/l
0.03
24
207
73
679
1.08
0.23
3.1
3.3
5.03
4.54
kpa
0.60
73
659
23
199
1.16
0.23
5.7
3.6
7.00
1.87
index
0.51
13
118
5
38
1.32
0.23
5.2
3.7
0.50
1.05
%
—
5
38
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
5
39
1.28
0.23
1.6
1.5
—
1903841.50
—
0
6
65
604
1.08
0.22
1.8
2.3
386.98
378.24
nmol/l
0.14
60
556
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
5
41
1.22
0.22
4.6
4.3
844.20
93.95
nmol/l
—
5
41
5
41
1.22
0.22
2.4
2.6
—
—
—
0
0
116
1102
1.06
0.22
7.6
7.5
1.06
1.02
mmol/l
0.79
107
1047
19
220
0.86
0.21
3.5
3.2
7.87
7.90
kpa
0.03
19
214
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
6658.20
—
0
5
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
5
43
1.16
0.21
1.0
1.1
263.00
310.82
mg/l
—
5
38
107
1016
1.06
0.21
7.1
9.6
1.12
0.71
mmol/l
0.52
92
832
108
1026
1.06
0.20
7.1
9.6
5.00
5.10
kpa
0.57
101
991
104
987
1.06
0.20
1.7
1.9
—
—
—
0
0
6
48
1.25
0.20
1.0
1.2
—
—
—
0
0
6
48
1.25
0.20
1.7
2.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.6
—
77.75
—
0
8
0
14
0.00
0.20
0.0
9.0
—
11.09
—
0
14
0
14
0.00
0.20
0.0
2.9
—
72.00
—
0
8
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
108
1027
1.06
0.20
7.0
9.6
11.55
11.99
kpa
0.44
103
995
6
49
1.23
0.20
1.3
1.7
—
—
—
0
0
6
49
1.23
0.20
1.3
1.7
—
—
—
0
0
40
365
1.10
0.20
2.4
2.9
—
—
—
0
0
26
231
1.13
0.20
1.6
1.8
—
—
—
0
0
7
58
1.21
0.18
1.3
1.6
—
—
—
0
0
17
195
0.87
0.18
1.1
1.3
—
—
—
0
0
18
204
0.88
0.16
1.2
1.2
—
—
—
0
0
21
235
0.89
0.16
1.2
1.1
27.61
142.75
u/ml
—
9
79
501
4949
1.03
0.16
24.2
23.8
13.82
13.77
%
0.27
495
4888
13
111
1.17
0.16
1.4
1.7
—
—
—
0
0
23
207
1.11
0.15
1.3
1.7
—
—
—
0
0
36
389
0.92
0.15
1.6
1.7
3.29
3.52
mmol/l
0.51
27
283
7
88
0.79
0.14
4.4
3.8
—
—
—
0
0
10
118
0.85
0.14
1.5
1.7
—
—
—
0
0
139
1346
1.04
0.14
1.6
1.7
1.25
1.59
mg/l
0.94
110
1059
62
652
0.95
0.13
2.7
3.1
288.57
232.84
ng/l
0.31
56
594
12
138
0.87
0.13
1.2
1.5
1622.25
1773.16
e6/l
0.07
12
98
14
123
1.14
0.12
1.3
1.2
—
—
—
0
0
19
171
1.11
0.12
3.0
9.8
104.58
105.56
mmol/l
0.48
19
153
10
85
1.18
0.12
1.0
1.2
—
—
—
0
0
86
827
1.04
0.12
7.2
8.9
11.27
11.28
mmol/l
0.00
80
795
70
730
0.95
0.11
2.0
2.5
9.49
8.49
ug/l
0.14
56
661
14
124
1.13
0.11
1.1
1.1
—
3.44
—
0
9
20
182
1.10
0.11
2.8
3.8
1.73
1.61
mmol/l
0.28
20
175
74
770
0.96
0.11
4.2
4.5
4.19
31.63
ug/l
1.72
64
642
20
183
1.10
0.10
2.5
1.9
14.12
12.45
mg/l
0.37
20
169
14
125
1.12
0.10
1.1
1.2
12.00
2.72
u/ml
—
5
13
16
176
0.91
0.09
2.9
2.8
16.94
16.30
%
0.29
16
170
16
145
1.11
0.09
1.4
1.7
18.26
18.37
ug/l
0.01
16
140
84
814
1.04
0.09
1.3
1.3
2.32
12.99
u/ml
3.27
28
300
6
55
1.09
0.09
2.2
1.5
81.67
90.40
umol/l
—
6
55
6
57
1.05
0.08
1.2
1.1
—
—
—
0
0
7
68
1.03
0.08
1.4
1.6
—
—
—
0
0
242
2451
0.98
0.07
4.8
4.5
11.63
10.83
mg/mmol
0.07
160
1705
7
84
0.83
0.07
1.3
2.9
953.29
1268.95
mg
—
7
84
14
129
1.09
0.05
1.4
1.3
—
—
—
0
0
215
2173
0.99
0.05
3.8
3.8
2.34
2.33
mmol/l
0.74
191
1978
34
327
1.04
0.05
1.1
1.3
861.40
293.36
u/ml
0.42
29
299
25
260
0.96
0.03
2.3
3.8
4.07
4.51
pmol/l
1.21
20
234
21
219
0.96
0.03
1.7
1.8
20.00
8.38
iu/ml
—
5
54
14
132
1.06
0.02
2.2
1.8
1.65
1.70
mmol/l
0.11
14
127
251
2521
0.99
0.01
4.2
3.7
8.16
8.46
mmol/l
0.48
202
2143
36
353
1.02
0.01
1.9
1.9
0.39
0.34
mg/l
0.17
19
191
78
787
0.99
0.01
4.3
3.6
—
—
—
0
0
13
134
0.97
0.00
1.0
1.1
—
—
—
0
0
16
163
0.98
0.00
1.4
1.3
—
—
—
0
0
16
163
0.98
0.00
1.4
1.3
—
—
—
0
0
16
158
1.01
0.00
2.9
4.0
7.73
7.68
mmol/l
0.02
16
152
11
109
1.01
0.00
5.4
5.9
342.73
345.44
umol/l
0.03
11
101
18
181
0.99
0.00
1.4
1.6
250.40
255.47
ug/g
—
10
117
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
5
50
1.00
0.00
6.2
9.5
—
70.41
—
0
17
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.3
—
20.50
—
0
7
41
410
1.00
-0.00
3.9
4.4
53.55
49.23
%
0.54
41
401
8
86
0.93
-0.00
1.0
1.2
1.44
1.60
nmol/l
—
8
77
6
59
1.02
-0.00
1.2
1.0
869.33
646.61
ng/l
—
6
36
6
59
1.02
-0.00
1.2
1.0
50.87
36.80
ng/l
—
6
34
0
5
0.00
-0.00
0.0
2.0
—
1.38
—
0
5
6
59
1.02
-0.00
1.2
1.0
351.67
283.22
ng/l
—
6
37
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_MALE_GEN and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_MALE_GEN | 1.301 [1.15, 1.47] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 965 out of 3809 males with CD2_BENIGN_MALE_GEN died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_MALE_GEN.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.238% |
| 5 | No data | 1.447% |
| 10 | No data | 3.479% |
| 15 | No data | 6.681% |
| 20 | No data | 11.102% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_MALE_GEN – Benign neoplasm of male genital organs
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data